From: Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy
Cycle | Absorbed dose (Gy) | Effective half-life (h) | 1 d uptake (MBq/ml) | ||||||
---|---|---|---|---|---|---|---|---|---|
G1 | G2 | p | G1 | G2 | p | G1 | G2 | p | |
#1 | 30 (23–36) | 18 (10–25) | 1.85E-03* | 118 (107–131) | 102 (84–123) | 2.48E-02 | 1.6 (1.3–2.1) | 1.0 (0.8–1.4) | 1.33E-02 |
#2 | 29 (21–38) | 19 (10–23) | 1.54E-03* | 118 (107–123) | 103 (91–120) | 4.11E-02 | 1.6 (1.4–2.3) | 1.2 (0.7–1.5) | 7.83E-03* |
#3 | 31 (19–45) | 16 (8–24) | 8.70E-04* | 131 (114–141) | 102 (88–120) | 9.42E-04* | 1.6 (1.2–2.1) | 0.9 (0.5–1.5) | 1.23E-02 |
#4 | 30 (19–34) | 18 (10–26) | 6.47E-03* | 114 (107–125) | 113 (99–133) | 7.71E-01 | 1.7 (1.1–1.9) | 0.9 (0.6–1.4) | 6.52E-03* |